Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
Cytokine|July 29, 2021
CX3CL1/fractalkine regulates the differentiation of human peripheral blood monocytes and monocyte-derived dendritic cells into osteoclastsSei Muraoka, Kaichi Kaneko, Kaori Motomura, et al.
Internal Medicine (Tokyo, Japan)|August 14, 2022
Efficacy of Denosumab for Osteoporosis in Patients with Rheumatic DiseasesKaichi Kaneko, Kotaro Shikano, Mai Kawazoe, et al.
Modern Rheumatology|September 3, 2008
Response of early active rheumatoid arthritis to tumor necrosis factor inhibitors: evaluation by magnetic resonance imagingWataru Hirose, Kenichiro Nishikawa, Masuko Hirose, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 14, 2011
Arthritic joint-targeting small interfering RNA-encapsulated liposome: implication for treatment strategy for rheumatoid arthritisYukiko Komano, Nobuhiro Yagi, Ikumi Onoue, et al.
Clinical Rheumatology|June 8, 2020
Clinical effectiveness of iguratimod based on real-world data of patients with rheumatoid arthritisSatoshi Mizutani, Hitoshi Kodera, Yoshiko Sato, et al.
Plos One|December 9, 2016
Apparent Hypothalamic-Pituitary-Adrenal Axis Suppression via Reduction of Interleukin-6 by Glucocorticoid Therapy in Systemic Autoimmune DiseasesNatsuki Fujio, Shotaro Masuoka, Kotaro Shikano, et al.
Modern Rheumatology|February 11, 2014
Recurrent mitral valve regurgitation with neutrophil infiltration in a patient with multiple aseptic abscessesShin Fukuda, Toshihiro Nanki, Tomohiro Morio, et al.
Modern Rheumatology|April 15, 2024
Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Up to 3-year results from a postmarketing surveillance studyHideto Kameda, Keiichiro Nishida, Toshihiro Nanki, et al.
Modern Rheumatology|July 13, 2022
Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Results from a 24-week post-marketing surveillance studyHideto Kameda, Keiichiro Nishida, Toshihiro Nanki, et al.
Clinical Rheumatology|May 29, 2017
Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseasesMai Kawazoe, Kaichi Kaneko, Kotaro Shikano, et al.
Pageof 13